Evaluation of nephrotic syndrome


Key articles

Waldman M, Appel GB. Update on the treatment of lupus nephritis. Kidney Int. 2006 Oct;70(8):1403-12. Abstract

Reference articles

1. Haas M, Meehan SM, Karrison TG, et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis. 1997 Nov;30(5):621-31. Abstract

2. Braden GL, Mulhern JG, O'Shea MH, et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis. 2000 May;35(5):878-83. Abstract

3. Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol. 2003 Mar;23(2):172-82. Abstract

4. Deegens JK, Wetzels JF. Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs Aging. 2007;24(9):717-32. Abstract

5. Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018 Nov;94(5):861-9. Abstract

6. Filler G, Young E, Geier P, et al. Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis. 2003 Dec;42(6):1107-13. Abstract

7. Vivarelli M, Massella L, Ruggiero B, et al. Minimal change disease. Clin J Am Soc Nephrol. 2017 Feb 7;12(2):332-45.Full text  Abstract

8. Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006 Jun;69(12):2251-60.Full text  Abstract

9. Farruggia P, Trizzino A, Maringhini S, et al. Hodgkin lymphoma and nephrotic syndrome in childhood. Indian J Pediatr. 2010 Oct;77(10):1147-9. Abstract

10. De Vriese AS, Sethi S, Nath KA, et al. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach. J Am Soc Nephrol. 2018 Mar;29(3):759-74.Full text  Abstract

11. Hinkes BG, Mucha B, Vlangos CN, et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics. 2007 Apr;119(4):e907-19.Full text  Abstract

12. Sadowski CE, Lovric S, Ashraf S, et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015 Jun;26(6):1279-89.Full text  Abstract

13. Glassock RJ. Secondary membranous glomerulonephritis. Nephrol Dial Transplant. 1992;7(suppl 1):64-71. Abstract

14. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009 Jul 2;361(1):11-21.Full text  Abstract

15. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med. 2011 Feb 17;364(7):689-90.Full text  Abstract

16. Ruggenenti P, Debiec H, Ruggiero B, et al. Anti-ohospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol. 2015 Oct;26(10):2545-58.Full text  Abstract

17. Kim YG, Choi YW, Kim SY, et al. Anti-phospholipase A2 receptor antibody as prognostic indicator in idiopathic membranous nephropathy. Am J Nephrol. 2015;42(3):250-7. Abstract

18. Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes. Diabetes Care. 2004 Jan;27(suppl 1):S79-83.Full text  Abstract

19. Hobeika L, Hunt KJ, Neely BA, et al. Comparison of the rate of renal function decline in nonproteinuric patients with and without diabetes. Am J Med Sci. 2015 Dec;350(6):447-52. Abstract

20. Piccoli GB, Grassi G, Cabiddu G, et al. Diabetic kidney disease: a syndrome rather than a single disease. Rev Diabet Stud. 2015 Spring-Summer;12(1-2):87-109.Full text  Abstract

21. Real de Asúa D, Costa R, Galván JM, et al. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol. 2014;6:369-77.Full text  Abstract

22. Ando Y, Coelho T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013 Feb 20;8:31.Full text  Abstract

23. Wheeler DC. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins. J Nephrol. Nov-Dec 2001;14(suppl 4):S70-5. Abstract

24. Barbano B, Gigante A, Amoroso A, et al. Thrombosis in nephrotic syndrome. Semin Thromb Hemost. 2013 Jul;39(5):469-76. Abstract

25. Remuzzi G, Mecca G, Marchesi D, et al. Platelet hyperaggregability and the nephrotic syndrome. Thromb Res. 1979;16(3-4):345-54. Abstract

26. Rodriguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis. Kidney Int. 2002 Oct;62(4):1379-84.Full text  Abstract

27. Kim SW, Frokiaer J, Nielsen S. Pathogenesis of oedema in nephrotic syndrome: role of epithelial sodium channel. Nephrology (Carlton). 2007 Dec;12(suppl 3):S8-S10. Abstract

28. van Husen M, Kemper MJ. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol. 2011 Jun;26(6):881-92. Abstract

29. Zhang S, Audard V, Fan Q, et al. Immunopathogenesis of idiopathic nephrotic syndrome. Contrib Nephrol. 2011;169:94-106. Abstract

30. Gbadegesin R, Lavin P, Foreman J, et al. Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatr Nephrol. 2011 Jul;26(7):1001-15. Abstract

31. lie V, Fakhoury M, Deschênes G, et al. Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol. 2012 Aug;27(8):1249-56. Abstract

32. El Bakkali L, Rodrigues Pereira R, Kuik DJ, et al. Nephrotic syndrome in the Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol. 2011 Aug;26(8):1241-6.Full text  Abstract

33. Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ. 2008 May 24;336(7654):1185-9.Full text  Abstract

34. Wenderfer SE. Viral-associated glomerulopathies in children. Pediatr Nephrol. 2015 Nov;30(11):1929-38.Full text  Abstract

35. Scottish Paediatric Renal and Urology Network. Idiopathic nephrotic syndrome in children, management. March 2017 [internet publication].Full text

36. National Institute for Health and Care Excellence. Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab. Evidence summary [ES1]. November 2016 [internet publication].Full text

37. De Vriese AS, Sethi S, Nath KA, et al. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach. J Am Soc Nephrol. 2018 Mar;29(3):759-74.Full text  Abstract

38. Pham TT, Sim JJ, Kujubu DA, et al. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol. 2007;27(3):322-8. Abstract

39. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol. 2011 Jul;31(4):341-8. Abstract

40. Bacchetta J, Juillard L, Cochat P, et al. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol. 2009 Apr;70(1):39-58. Abstract

41. Luciano RL, Moeckel GW. Update on the native kidney biopsy: core curriculum 2019. Am J Kidney Dis. 2019 Mar;73(3):404-15.Full text  Abstract

42. Bobart SA, De Vriese AS, Pawar AS, et al. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int. 2019 Feb;95(2):429-38.Full text  Abstract

43. Stout LC, Kumar S, Whorton EB. Focal mesangiolysis and the pathogenesis of the Kimmelstiel-Wilson nodule. Hum Pathol. 1993 Jan;24(1):77-89. Abstract

44. Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006 Dec;17(12):3458-71.Full text  Abstract

45. Waldman M, Appel GB. Update on the treatment of lupus nephritis. Kidney Int. 2006 Oct;70(8):1403-12. Abstract

46. Bradwell AR, Carr-Smith HD, Mead GP, et al. Serum test for assessment of patients with Bence Jones myeloma. Lancet. 2003 Feb 8;361(9356):489-91. Abstract

47. Barbour T, Johnson S, Cohney S, et al. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant. 2012 Jul;27(7):2673-85.Full text  Abstract

Use of this content is subject to our disclaimer